Rubius Therapeutics
RUBY
$0.02198
Share price
7.74%
Change (1 day)
-98.28%
Change (1 year)
Categories
Rubius Therapeutics (RUBY) - Cash on Hand
Cash on Hand as of December 2022 : $18.93 M
According to Rubius Therapeutics
's latest financial reports the company has $18.93 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Rubius Therapeutics - Cash on Hand chart (from 2017 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $18.93 M | -91.62% |
| 2021-12-31 | $0.22 B | 28.11% |
| 2020-12-31 | $0.17 B | -37.77% |
| 2019-12-31 | $0.28 B | -29.89% |
| 2018-12-31 | $0.40 B | 287.44% |
| 2017-12-31 | $0.10 B | 1426.02% |
| 2016-12-31 | $6.83 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 999.48% | 🇺🇸 USA |